Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
DAYLI Partners is a venture capital firm founded around 2018 and based in Seoul, South Korea. The firm focuses on advancing innovation in the bio-healthcare and financial governance sectors. With a multidisciplinary team composed of healthcare and finance professionals, DAYLI Partners utilizes its extensive industry knowledge to identify and support transformative companies in these fields.
Currently, DAYLI Partners manages approximately $300 million in assets under management (AUM) and has built a diverse portfolio of over 80 companies. The firm has established a strong presence in both North America and Asia, actively seeking opportunities that align with its investment thesis. Notable milestones include partnerships with organizations like Toronto Innovation Acceleration Partners (TIAP) to create a biotech fund in Canada, showcasing its commitment to fostering innovation across borders.
DAYLI Partners invests primarily in the bio-healthcare and financial governance sectors, targeting companies at the Series A, Series B, and pre-IPO stages. The firm is particularly interested in advancements in therapeutics, diagnostics, medical devices, and digital health. Their investment strategy is driven by a team that includes MDs, PhDs, and PharmDs, who focus on innovative solutions within the life sciences stack.
The firm emphasizes the importance of identifying companies that demonstrate potential for significant growth and impact in the bio-healthcare space. DAYLI Partners seeks founders who possess a strong vision and the capability to navigate the complexities of the healthcare landscape. The firm is open to co-investment opportunities and values strategic partnerships that can enhance the growth trajectory of its portfolio companies.
DAYLI Partners has a diverse portfolio of over 80 companies, reflecting its commitment to the bio-healthcare sector. Notable investments include:
This portfolio showcases DAYLI Partners' strategy of investing in companies that are at the forefront of bio-healthcare innovation. The firm actively supports its portfolio companies through strategic guidance and access to a network of industry experts, helping them navigate the complexities of the bio-healthcare landscape.
DAYLI Partners Team - The firm comprises a multidisciplinary team of healthcare and finance professionals, although specific names and titles are not disclosed in the available data. The team includes individuals with expertise in science, medicine, law, and finance, which enhances the firm's ability to evaluate and support investments in the bio-healthcare sector.
This diverse background allows DAYLI Partners to provide tailored support to portfolio companies, leveraging their collective knowledge to navigate the complexities of the bio-healthcare landscape effectively.
To pitch DAYLI Partners, founders should send an email to contact@dayli.partners. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and team qualifications. While specific response time expectations are not disclosed, founders should anticipate a thorough review process given the firm's specialized focus.
Warm introductions are preferred, as they can facilitate a more favorable reception of the pitch. Founders should ensure that their decks are concise yet informative, highlighting key metrics and milestones achieved to date.
In 2024, DAYLI Partners made notable investments in ALDAVER and DAAN Biotherapeutics, both securing Series A funding. These investments reflect the firm's commitment to supporting innovative solutions in the bio-healthcare sector.
Additionally, DAYLI Partners has been active in establishing partnerships, such as its collaboration with Toronto Innovation Acceleration Partners (TIAP) to create a biotech fund in Canada, announced in 2019. This partnership aims to enhance investment opportunities in the life sciences across North America.
What are DAYLI Partners' investment criteria?
DAYLI Partners focuses on investments in the bio-healthcare and financial governance sectors, particularly at the Series A, Series B, and pre-IPO stages. The firm seeks companies that demonstrate innovative solutions in therapeutics, diagnostics, medical devices, and digital health.
How can I pitch to DAYLI Partners?
Founders can reach out to DAYLI Partners via email at contact@dayli.partners. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes DAYLI Partners different from other VCs?
DAYLI Partners distinguishes itself through its specialized focus on bio-healthcare and financial governance, supported by a multidisciplinary team with deep industry expertise. This allows them to provide tailored support to portfolio companies.
What is the geographic focus of DAYLI Partners?
The firm primarily invests in North America and Asia, leveraging its strong network across these regions to identify promising investment opportunities.
What kind of support do portfolio companies receive?
DAYLI Partners adds value through strategic guidance, access to a network of industry experts, and assistance in navigating the complexities of the bio-healthcare landscape. The firm aims to help companies achieve their growth objectives effectively.
What is the typical check size for investments?
While specific check sizes are not disclosed, DAYLI Partners invests at the Series A, Series B, and pre-IPO stages, indicating a range that typically aligns with these funding rounds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.